NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ·Healthcare·Biotechnology
$0.81
+8.10%
Mkt Cap $20.73M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 6, 2026 | — | — | — | -$0.07 | -$0.22 | -210.73% | — | — |
| Q4 2025 Dec 17, 2025 | — | — | — | — | -$0.11 | — | — | — |
| Q2 2025 May 28, 2025 | — | — | — | -$0.10 | -$0.11 | -4.80% | — | — |
| Q2 2025 Apr 7, 2025 | — | — | — | -$0.11 | -$0.06 | +45.45% | — | — |
| Q4 2024 Dec 18, 2024 | — | — | — | -$0.16 | -$0.11 | +31.25% | — | — |
| Q3 2024 Sep 30, 2024 | — | — | — | -$0.20 | -$0.02 | +90.00% | — | — |
| Q2 2024 Apr 5, 2024 | — | — | — | -$0.20 | -$0.16 | +20.00% | — | — |
| Q1 2024 Mar 22, 2024 | — | — | — | -$0.20 | -$0.16 | +20.00% | — | — |
| Q4 2023 Nov 28, 2023 | — | — | — | -$0.24 | $0.10 | +141.67% | — | — |
| Q3 2023 Aug 16, 2023 | — | — | — | -$0.28 | -$0.44 | -57.14% | — | — |
| Q2 2023 Jun 1, 2023 | — | — | — | -$0.29 | -$0.33 | -13.79% | — | — |
| Q1 2023 Mar 22, 2023 | — | — | — | -$0.28 | -$0.27 | +3.57% | — | — |
| Q4 2022 Dec 1, 2022 | — | — | — | -$0.28 | -$0.25 | +10.71% | — | — |
| Q3 2022 Aug 31, 2022 | — | — | — | -$0.28 | -$0.31 | -10.71% | — | — |
| Q2 2022 May 31, 2022 | — | — | — | -$0.18 | -$0.24 | -33.33% | — | — |
| Q2 2022 Apr 14, 2022 | — | — | — | -$0.16 | -$0.24 | -50.00% | — | — |
| Q4 2021 Dec 10, 2021 | — | — | — | — | -$0.08 | — | — | — |
| Q3 2021 Sep 21, 2021 | — | — | — | — | -$0.19 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.08 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.20 | — | — | — |